Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL
- Yanan Wang, MSC1⇓,
- Marieke Snel, MD2,
- Jacqueline T. Jonker, MD1,3,
- Sebastiaan Hammer, MD, PHD3,
- Hildo J. Lamb, MD, PHD3,
- Albert de Roos, MD, PHD3,
- A. Edo Meinders, MD, PHD2,
- Hanno Pijl, MD, PHD1,
- Johannes A. Romijn, MD, PHD1,
- Johannes W.A. Smit, MD, PHD1,
- Ingrid M. Jazet, MD, PHD2 and
- Patrick C.N. Rensen, PHD1,2
- 1Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands
- 2Department of General Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands
- 3Department of Radiology, Leiden University Medical Center, Leiden the Netherlands
- Corresponding author: Yanan Wang, .
M.S. and J.T.J. contributed equally to this work.
OBJECTIVE Using a mouse model for human-like lipoprotein metabolism, we observed previously that reduction of the hepatic triglyceride (TG) content resulted in a decrease in plasma cholesteryl ester transfer protein (CETP) and an increase in HDL levels. The aim of the current study was to investigate the effects of prolonged caloric restriction in obese patients with type 2 diabetes mellitus, resulting in a major reduction in hepatic TG content, on plasma CETP and HDL levels.
RESEARCH DESIGN AND METHODS We studied 27 obese (BMI: 37.2 ± 0.9 kg/m2) insulin-dependent patients with type 2 diabetes mellitus (14 men and 13 women, aged 55 ± 2 years) who received a 16-week very low calorie diet (VLCD). At baseline and after a 16-week VLCD, plasma lipids, lipoproteins, and CETP were measured. Furthermore, functionality of HDL with respect to inducing cholesterol efflux from human monocyte cells (THP-1) was determined.
RESULTS A 16-week VLCD markedly decreased plasma CETP concentration (−18%; P < 0.01) and increased plasma apolipoprotein (apo)AI levels (+16%; P < 0.05), without significantly affecting plasma HDL-cholesterol and HDL-phospholipids. Although a VLCD results in HDL that is less lipidated, the functionality of HDL with respect to inducing cholesterol efflux in vitro was unchanged.
CONCLUSIONS The marked decrease in hepatic TG content induced by a 16-week VLCD is accompanied by a decrease in plasma CETP concentration and an increase in apoAI levels, without improving the cholesterol efflux properties of HDL in vitro.
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc11-0685/-/DC1.
- Received April 20, 2011.
- Accepted September 6, 2011.
- © 2011 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.